Trend Results : The Mount Sinai


Blog Post Results (1-20 of 1037)

FILTER RESULTS

I Never Get The Flu, So Why Do I Need A Flu Shot?

Brian S. Koll, MD Recently retired as Executive Medical Director for Infection Prevention and Control, Mount Sinai Health

Novel therapeutic target discovered for estrogen receptor positive (ER+) breast cancer

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers identify new protein in a common subtype of breast cancer which can potentially offer more effective therapies for the future.

Mount Sinai Researcher Appointed as Next Generation Leader for the Allen Institute for Brain Science

Denise Cai, PhD, Assistant Professor of Neuroscience at the Icahn School of Medicine at Mount Sinai, has been selected as one of the Allen Institute for Brain Science's 2017 Next Generation Leaders.

Five Health Indicators Are Enough to Predict Cardiovascular Risk in Healthy People, Mount Sinai Researchers Report

In a large population study that was the first of its kind, researchers found that a simple tool not requiring laboratory tests, the Fuster-BEWAT score, is as effective as the American Heart Association-recommended ICHS (Ideal Cardiovascular Health Index), which includes blood analysis of cholesterol and glucose.

Mount Sinai Taps MuleSoft to Create API Economy to Share Patient Data

MuleSoft, an application network company, announced Mount Sinai, New York’s largest integrated health system is leveraging Anypoint Platform to broaden its ability to share data beyond the four walls of its hospitals. Historically, Mount...Show More Summary

Mount Sinai Researchers Develop First Mathematical Model for Predicting Patient Response to Immunotherapy

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

Mount Sinai scientists create first mathematical model that predicts immunotherapy success

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

Microfinance institutions are found effective in giving health products to underserved communities

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Microfinance institutions are found effective in delivering essential health products to underserved communities on a national scale while reducing costs.

Two Mount Sinai Institutes to Join $215 Million Public-Private Partnership to Increase Patients' Immunotherapy Success

The Tisch Cancer Institute and the Precision Immunology Institute at Mount Sinai Health System are part of a $215 million public-private Cancer Moonshot research collaboration launched by the National Institutes of Health and 11 leading pharmaceutical companies.

Microfinance Institutions Are Found Effective in Delivering Essential Health Products to Underserved Communities on a National Scale While Reducing Costs

New research from The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai, suggests that the capabilities of microfinance networks expand well beyond banking, and that tapping into these networks can bring measurable health improvements to rural and underserved communities on a national scale with reduced cost.

What Is Urgent Care, And When Is It The Right Choice?

Erick Eiting, MD Assistant Professor, Emergency Medicine Icahn School of Medicine at Mount Sinai Director of Emergency Medicine

R. Sean Morrison, MD, Appointed System Chair of the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai

R. Sean Morrison, MD, has been appointed the Ellen and Howard C. Katz Chair of the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS).

Mount Sinai's Raja M. Flores, MD, Is Honored by the NYPD

One of 13 physicians appointed as a member of the Society of Honorary Police Surgeons of the City of New York

Three Mount Sinai Researchers Elected to National Academy of Medicine

Three faculty members from the Icahn School of Medicine at Mount Sinai have been elected to the National Academy of Medicine (NAM).

National Grant Awarded to Icahn School of Medicine at Mount Sinai to Continue the New York Traumatic Brain Injury Model System

The National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) has awarded the Icahn School of Medicine at Mount Sinai's Department of Rehabilitation Medicine and the Brain Injury Research Center a five-year grant totaling $2.2 million to fund the New York Traumatic Brain Injury Model System at Mount Sinai to study traumatic brain injury (TBI).

Mount Sinai Professor of Geriatrics and Palliative Care Medicine and Center for Advance Palliative Care Director Diane E. Meier, MD Receives National Academy of Medicine Lienhard Award for Leading Palliative Care Adoption in the United States

Diane E. Meier, MD, director of the Center to Advance Palliative Care (CAPC) and professor of geriatrics and palliative care medicine at the Icahn School of Medicine at Mount Sinai, has been named the 32nd recipient of the Gustav O. Lienhard Award for Advancement in Healthcare, announced today by the National Academy of Medicine.

Mount Sinai & Sema4 scientists identify biomarker for progression and drug response in brain cancer

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies. Show More Summary

Mount Sinai & Sema4 scientists identify biomarker for progression and drug response in brain cancer

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported...Show More Summary

Mount Sinai Opens New Multi-Specialty Practice in Queens with Ribbon Cutting and Health Fair

The Mount Sinai Health System is opening a new state-of-the-art medical practice to serve the Rego Park/Forest Hills community.

Myron Schwartz, MD, Honored With 2017 New York Physician of the Year Award from The American Liver Foundation's Greater New York Division

Myron Schwartz, MD, the Henry Kaufmann Professor of Surgery at the Icahn School of Medicine at Mount Sinai and Director of Liver Surgery at the Recanati/Miller Transplantation Institute, has been named as the 2017 Physician of the Year by the American Liver Foundation's Greater New York Division.

Copyright © 2015 Regator, LLC